Xuesaitong for heart disease risk factors
Part of Heart & circulation clinical trials.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stable coronary artery disease for at least 3 months (for example, you had a heart attack, had a stent placed, or have chest pain with evidence of blockage).
- Your blood test shows a high-sensitivity C-reactive protein (hs-CRP) level of 2 mg/L or higher.
- You are currently taking a moderate or strong statin (a cholesterol-lowering drug).
- You are currently taking an antiplatelet medication (like aspirin or clopidogrel).
- You have not had a recent heart attack, stroke, heart failure with low pumping function, or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Yangxinshi tablets can help people with coronary heart disease and some degree of heart failure. It looks at improving heart function and safety over the treatment period.
This trial tests whether a tailored prevention plan can improve outcomes and help with costs for people at high risk of coronary heart disease. You may join if you’ve had recent heart events or scans show significant blockage, and if you can follow the visit and app requirements.
This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
This trial tests a Chinese herbal medicine called Aromatic Wentong for people with coronary microvascular disease—a condition where the tiny blood vessels in the heart don't work properly, causing chest pain. The medicine may help improve blood flow in the small vessels.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.